广州招聘

Major Responsibilities

• Identify Key Opinion Leaders (KOLs) and establish and maintain scientific relationships with KOLs; connecting KOLs in academic and community centers.
• Act as primary liaison to investigators interested in developing and performing investigator initiated research
• Develop and execute territory plans in alignment with regional and national medical communication plans
• Provide clinical presentations and information in response to unsolicited questions (as appropriate) in academic, community, and healthcare provider setting in both group and one-on-one situations
• Provide medical support to cross functions
• Provide support to clinical development trials from medical affairs perspective
• Provide timely feedback/information on emerging clinical/scientific teams and opportunities to internal stakeholders
• Develop and present internal therapeutic area training modules. Provide congress updates and act as a point of medical/ scientific expertise internally for ad-hoc as well as structured training requests.
• Responds to Health Care Providers requests for clinical / scientific information
• Works in a compliant manner and contributes to the culture of the wider team in up-skilling compliance skills

Qualification

• Ability to synthesize recent scientific information, analyze them within strategic and regulatory settings.
• Proven ability to work independently as well as in networks including with internal and external stakeholders.
• Ability to partner and maintain relationships within the medical community
• Excellent communication, presentation and time management skills
• Fluent in spoken and written English is required
• Demonstrated initiative, creativity, strategic capabilities, and ability to work effectively in complex, rapidly changing environments
• Strong project and process building and management skills, along with the ability to work on multiple tasks, and to effectively prioritize.
• Proven team player with ability to navigate cross functionally.
• Values consistent with BeiGene values

2017年3月，百济神州与广州开发区合作，建设生物药生产基地，直接投资额达22亿人民币。广州生物药生产基地主要生产大分子单克隆抗体类抗癌药。基地采用全球领先的现代生产设备KUBio整体解决方案。

我们的目标是致力于成为一家在癌症研究、药物研发、人才培养和商业准则方面具有全球影响力的公司。
在这里，您的每一分努力都将得到肯定，您的个人价值将在公司的发展中得到充分的体现。